scholarly journals Gestational Diabetes: Evidence-Based Screening, Diagnosis and Treatment

10.5772/23392 ◽  
2011 ◽  
Author(s):  
Melania Maria Ramos Amorim ◽  
Leila Katz
Author(s):  
Bernd Schulte ◽  
Christina Lindemann ◽  
Angela Buchholz ◽  
Anke Rosahl ◽  
Martin Härter ◽  
...  

Abstract. Background: The German Guideline on Screening, Diagnosis and Treatment of Alcohol Use Disorders aims to increase the uptake of evidence-based interventions for the early identification, diagnosis, prevention and treatment of alcohol-related disorders in relevant healthcare settings. To date, dissemination has not been accompanied by a guideline implementation strategy. The aim of this study is to develop tailored guideline implementation strategies and to field-test these in relevant medical and psycho-social settings in the city of Bremen, Germany. Methods: The study will conduct an impact and needs assessment of healthcare provision for alcohol use orders in Bremen, drawing on a range of secondary and primary data to: evaluate existing healthcare services; model the potential impact of improved care on public health outcomes; and identify potential barriers and facilitators to implementing evidence-based guidelines. Community advisory boards will be established for the selection of single-component or multi-faceted guideline implementation strategies. The tailoring approach considers guideline, provider and organizational factors shaping implementation. In field tests quality outcome indicators of the delivery of evidence-based interventions will be evaluated accompanied by a process evaluation to examine patient, provider and organizational factors. Outlook: This project will support the translation of guideline recommendations for the identification, prevention and treatment of AUD in routine practice and therefore contributes to the reduction of alcohol-related burden in Germany. The project is running since October 2017 and will provide its main outcomes by end of 2020. Project results will be published in scientific journals and presented at national and international conferences.


2019 ◽  
Vol 126 (1) ◽  
pp. 6-13 ◽  
Author(s):  
Filippo Pinto e Vairo ◽  
Bruna Cristine Chwal ◽  
Silvana Perini ◽  
Maria Angélica Pires Ferreira ◽  
Ana Carolina de Freitas Lopes ◽  
...  

2017 ◽  
Vol 76 (12) ◽  
pp. 1965-1973 ◽  
Author(s):  
Noortje Groot ◽  
Nienke de Graeff ◽  
Stephen D Marks ◽  
Paul Brogan ◽  
Tadej Avcin ◽  
...  

Lupus nephritis (LN) occurs in 50%–60% of patients with childhood-onset systemic lupus erythematosus (cSLE), leading to significant morbidity. Timely recognition of renal involvement and appropriate treatment are essential to prevent renal damage. The Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative aimed to generate diagnostic and management regimens for children and adolescents with rheumatic diseases including cSLE. Here, we provide evidence-based recommendations for diagnosis and treatment of childhood LN. Recommendations were developed using the European League Against Rheumatism standard operating procedures. A European-wide expert committee including paediatric nephrology representation formulated recommendations using a nominal group technique. Six recommendations regarding diagnosis and 20 recommendations covering treatment choices and goals were accepted, including each class of LN, described in the International Society of Nephrology/Renal Pathology Society 2003 classification system. Treatment goal should be complete renal response. Treatment of class I LN should mainly be guided by other symptoms. Class II LN should be treated initially with low-dose prednisone, only adding a disease-modifying antirheumatic drug after 3 months of persistent proteinuria or prednisone dependency. Induction treatment of class III/IV LN should be mycophenolate mofetil (MMF) or intravenous cyclophosphamide combined with corticosteroids; maintenance treatment should be MMF or azathioprine for at least 3 years. In pure class V LN, MMF with low-dose prednisone can be used as induction and MMF as maintenance treatment. The SHARE recommendations for diagnosis and treatment of LN have been generated to support uniform and high-quality care for all children with SLE.


2014 ◽  
Vol 12 (S1) ◽  
Author(s):  
Nienke de Graeff ◽  
Noortje Groot ◽  
Sylvia Kamphuis ◽  
Tadej Avcin ◽  
Brigitte Bader-Meunier ◽  
...  

Author(s):  
Alfred J. Finch ◽  
John E. Lochman ◽  
W. Michael Nelson III ◽  
Michael C. Roberts

Chapter 10 discusses how the identity of the clinical child and adolescent psychologist forms as someone with specialized competencies and skills to provide services to children and adolescents and their families, and to conduct research into issues of development, psychotherapy, assessment and diagnosis, and treatment. It also covers how this identity is partially achieved through membership in professional organizations, personal continuing efforts to maintain competences and develop new skills, and advanced credentials or board certification in clinical child and adolescent psychology. It addresses that, although membership in professional organizations does not automatically bestow competencies or credentials on a specialty psychologist, it does permit the clinical child and adolescent psychologist to monitor changes in the field, remain current with evidence-based practice and scientific advances, seek counsel on clinical challenges and ethical dilemmas, and gain support from the specialty community of practitioners and scholars.


Sign in / Sign up

Export Citation Format

Share Document